Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1371091.RA9JeAnjHvOpCODy4X-t__4mTcXUN6Hjz2NySsNanEYYM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1371091.RA9JeAnjHvOpCODy4X-t__4mTcXUN6Hjz2NySsNanEYYM130_assertion type Assertion NP1371091.RA9JeAnjHvOpCODy4X-t__4mTcXUN6Hjz2NySsNanEYYM130_head.
- NP1371091.RA9JeAnjHvOpCODy4X-t__4mTcXUN6Hjz2NySsNanEYYM130_assertion description "[In Group I this was associated with improvements in PEFR, FEV1 and night time wheeze and reduced percentages of CD4/CD25 and CD4/HLA-DR peripheral blood T cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1371091.RA9JeAnjHvOpCODy4X-t__4mTcXUN6Hjz2NySsNanEYYM130_provenance.
- NP1371091.RA9JeAnjHvOpCODy4X-t__4mTcXUN6Hjz2NySsNanEYYM130_assertion evidence source_evidence_literature NP1371091.RA9JeAnjHvOpCODy4X-t__4mTcXUN6Hjz2NySsNanEYYM130_provenance.
- NP1371091.RA9JeAnjHvOpCODy4X-t__4mTcXUN6Hjz2NySsNanEYYM130_assertion SIO_000772 9113946 NP1371091.RA9JeAnjHvOpCODy4X-t__4mTcXUN6Hjz2NySsNanEYYM130_provenance.
- NP1371091.RA9JeAnjHvOpCODy4X-t__4mTcXUN6Hjz2NySsNanEYYM130_assertion wasDerivedFrom befree-2016 NP1371091.RA9JeAnjHvOpCODy4X-t__4mTcXUN6Hjz2NySsNanEYYM130_provenance.
- NP1371091.RA9JeAnjHvOpCODy4X-t__4mTcXUN6Hjz2NySsNanEYYM130_assertion wasGeneratedBy ECO_0000203 NP1371091.RA9JeAnjHvOpCODy4X-t__4mTcXUN6Hjz2NySsNanEYYM130_provenance.